Page 90 - Immunization Practices News Today

Nathan Posner/Anadolu Agency via Getty Images(WASHINGTON) -- A respiratory syncytial virus, or RSV, vaccine for older adults could soon be available after an advisory committee for the Centers for Disease Control and Prevention voted to recommend them Wednesday. During a meeting, the agencys Advisory Committee on Immunization Practices looked at clinical trial data for two vaccines, one by Pfizer and the other by GSK. Short of a full recommendation, the committee said adults aged 60 and over may...

Nathan Posner/Anadolu Agency via Getty Images(WASHINGTON) -- A respiratory syncytial virus, or RSV, vaccine for older adults could soon be available after an advisory committee for the Centers for Disease Control and Prevention voted to recommend them Wednesday. During a meeting, the agencys Advisory Committee on Immunization Practices looked at clinical trial data for two vaccines, one by Pfizer and the other by GSK. Short of a full recommendation, the committee said adults aged 60 and over may...

Nathan Posner/Anadolu Agency via Getty Images(WASHINGTON) -- A respiratory syncytial virus, or RSV, vaccine for older adults could soon be available after an advisory committee for the Centers for Disease Control and Prevention voted to recommend them Wednesday. During a meeting, the agencys Advisory Committee on Immunization Practices looked at clinical trial data for two vaccines, one by Pfizer and the other by GSK. Short of a full recommendation, the committee said adults aged 60 and over may...

CDC advisors on Thursday unanimously supported the addition of Pfizer’s 20-valent pneumococcal vaccine as an option for children in the United States.

New high-risk conditions added as well, including chronic kidney disease and asthma

Adults 60 and older will be eligible to get a shot that could protect them from RSV this fall if the CDC follows advice from its vaccine advisory committee.

PHILADELPHIA--(BUSINESS WIRE)--Jun 21, 2023--

(Alliance News) - GSK PLC on Thursday said the US Centers for Disease Control & Preventions Advisory Committee on Immunization Practices has voted to recommend the firms Arexvy jab in adults aged 60 and older. The Brentford, London-based pharmaceu...

By Anthony O. Goriainoff GSK said Thursday that the U.S. Centers for Disease Control and Preventions Advisory Committee on Immunization Practices, or ACIP, has voted to recommend its respiratory syncytial virus vaccine Arexvy for the prevention o...

The respiratory illness RSV can be serious, especially in children and older adults.